Caner Saygin to Drugs, Investigational
This is a "connection" page, showing publications Caner Saygin has written about Drugs, Investigational.
Connection Strength
0.146
-
Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates. JCO Clin Cancer Inform. 2017 11; 1:1-14.
Score: 0.146